These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1610984)

  • 1. Effect of n-3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients.
    Donnelly SM; Ali MA; Churchill DN
    J Am Soc Nephrol; 1992 May; 2(11):1634-9. PubMed ID: 1610984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fish oil supplements in NIDDM subjects. Controlled study.
    Hendra TJ; Britton ME; Roper DR; Wagaine-Twabwe D; Jeremy JY; Dandona P; Haines AP; Yudkin JS
    Diabetes Care; 1990 Aug; 13(8):821-9. PubMed ID: 2209315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic effects of omega-3 fatty acids (fish oil) in a rat 5/6 renal ablation model.
    Clark WF; Parbtani A; Philbrick DJ; Holub BJ; Huff MW
    J Am Soc Nephrol; 1991 Jun; 1(12):1343-53. PubMed ID: 1912396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease.
    Bairati I; Roy L; Meyer F
    Can J Cardiol; 1992; 8(1):41-6. PubMed ID: 1617510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n-3 fatty acids in mildly hyperlipidemic males.
    Cobiac L; Clifton PM; Abbey M; Belling GB; Nestel PJ
    Am J Clin Nutr; 1991 May; 53(5):1210-6. PubMed ID: 1826986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia.
    Simons LA; Hickie JB; Balasubramaniam S
    Atherosclerosis; 1985 Jan; 54(1):75-88. PubMed ID: 3888229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fish oil modifies lipids and reduces platelet aggregability in haemodialysis patients.
    Rylance PB; Gordge MP; Saynor R; Parsons V; Weston MJ
    Nephron; 1986; 43(3):196-202. PubMed ID: 3724927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients.
    Annuzzi G; Rivellese A; Capaldo B; Di Marino L; Iovine C; Marotta G; Riccardi G
    Atherosclerosis; 1991 Mar; 87(1):65-73. PubMed ID: 1872925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Maxepa on serum lipids in hypercholesterolaemic subjects.
    Dart AM; Riemersma RA; Oliver MF
    Atherosclerosis; 1989 Dec; 80(2):119-24. PubMed ID: 2692571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does vegetable oil attenuate the beneficial effects of fish oil in reducing risk factors for cardiovascular disease?
    Hwang DH; Chanmugam PS; Ryan DH; Boudreau MD; Windhauser MM; Tulley RT; Brooks ER; Bray GA
    Am J Clin Nutr; 1997 Jul; 66(1):89-96. PubMed ID: 9209174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dietary marine oils and olive oil on fatty acid composition, platelet membrane fluidity, platelet responses, and serum lipids in healthy humans.
    Vognild E; Elvevoll EO; Brox J; Olsen RL; Barstad H; Aursand M; Osterud B
    Lipids; 1998 Apr; 33(4):427-36. PubMed ID: 9590631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on blood lipids and haemostasis of a supplement of cod-liver oil, rich in eicosapentaenoic and docosahexaenoic acids, in healthy young men.
    Sanders TA; Vickers M; Haines AP
    Clin Sci (Lond); 1981 Sep; 61(3):317-24. PubMed ID: 6266735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial.
    Toft I; Bønaa KH; Ingebretsen OC; Nordøy A; Jenssen T
    Ann Intern Med; 1995 Dec; 123(12):911-8. PubMed ID: 7486485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.
    Vidgren HM; Agren JJ; Schwab U; Rissanen T; Hänninen O; Uusitupa MI
    Lipids; 1997 Jul; 32(7):697-705. PubMed ID: 9252957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of supplemented omega-3 and omega-6 fatty acid rich oils on the cardiovascular system of thermally injured rabbits: changes in plasma and platelet fatty acids.
    Kirmani ZA; Baxter CR; Gorman MA; Ashby J; Ireton-Jones C; Liepa GU
    J Burn Care Rehabil; 1995; 16(2 Pt 1):173-9; discussion 172. PubMed ID: 7775514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the absorption and effect on platelet function of a single dose of n-3 fatty acids given as fish or fish oil.
    Silverman DI; Ware JA; Sacks FM; Pasternak RC
    Am J Clin Nutr; 1991 May; 53(5):1165-70. PubMed ID: 1826984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation with n-3 fatty acids reduces triglycerides but increases PAI-1 in non-insulin-dependent diabetes mellitus.
    Boberg M; Pollare T; Siegbahn A; Vessby B
    Eur J Clin Invest; 1992 Oct; 22(10):645-50. PubMed ID: 1459169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.
    Viecelli AK; Pascoe E; Polkinghorne KR; Hawley C; Paul-Brent PA; Badve SV; Cass A; Heritier S; Kerr PG; Mori TA; Robertson A; Seong HL; Irish AB;
    BMC Nephrol; 2015 Jun; 16():89. PubMed ID: 26116581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled trial of fish oil concentrate (MaxEpa) in stroke patients.
    Green D; Barreres L; Borensztajn J; Kaplan P; Reddy MN; Rovner R; Simon H
    Stroke; 1985; 16(4):706-9. PubMed ID: 3895595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.